Skip to main content
. 2021 Mar 25;64(7):3508–3545. doi: 10.1021/acs.jmedchem.0c01808

Table 1. BzR Affinity for Compounds 1416a.

2.1.

      Ki (nM) or % inhibition (10 μM)b,c
cpd R1 X bovine brain membranes α1β2γ2 α2β2γ2 α5β3γ2
14c H H 120 ± 11 346 ± 29 39% ± 3 46% ± 5
15d NO2 H 117 ± 12 65 ± 5 32% ± 3 44% ± 4
16e NO2 CH3 88 ± 6 31.3 ± 2 0% 0%
diazepam     10 ± 1      
flumazenil     0.90 ± 0.05      
clonazepam     0.85 ± 0.02      
a

Ki (nM) or % inhibition (10 μM) data of indol-3-ylglyoxylylamide derivatives 1416.

b

Ki represents the means ± SEM of three determinations performed in triplicate.

c

Inhibition percentages of specific [3H]-flumazenil binding at 10 μM represent the means ± SEM of three determinations performed in triplicate.

d

Data are from Da Settimo et al.50

e

Data are from Primofiore et al.52